Bill
Bill > AJR219
NJ AJR219
NJ AJR219Designates September of each year as "Duchenne Muscular Dystrophy Awareness Month" in NJ.
summary
Introduced
03/06/2025
03/06/2025
In Committee
03/06/2025
03/06/2025
Crossed Over
Passed
Dead
01/12/2026
01/12/2026
Introduced Session
2024-2025 Regular Session
Bill Summary
This bill designates September of each year as "Duchenne Muscular Dystrophy Awareness Month" in New Jersey. Duchenne muscular dystrophy (DMD) is a muscular degenerative disease that results in the progressive loss of muscle tissue and function. DMD is caused by genetic mutations on the X chromosome, which affects approximately 1 out of every 3,500 male infants. Symptoms of DMD generally present between ages two and three and rapidly progress, with many individuals with DMD requiring wheelchair assistance between ages 10 and 12 and a breathing ventilator by age 20. Individuals with DMD may also experience paralysis and cardiopulmonary complications, including difficulty breathing or heart failure. DMD is a fatal disease with an average life expectancy of 25 years. While there is no cure for DMD, non-profit organizations across the country and in New Jersey are dedicated to raising awareness of DMD, advocating for improved care and access to treatment, and funding research to cure this devastating disease. Efforts to improve patients' access to treatment are critical as research indicates that optimal care can help to significantly increase the life expectancy for individuals with DMD. In addition, increasing awareness of DMD may help promote empathy and understanding, foster a sense of community, strengthen advocacy efforts, and encourage social and emotional support for the young people and families affected by DMD. To join and support ongoing public awareness and advocacy efforts, September of each year is designated as "Duchenne Muscular Dystrophy Awareness Month" in New Jersey. The Governor is requested to issue a proclamation annually to recognize September of each year as "Duchenne Muscular Dystrophy Awareness Month" and call upon relevant State agencies, organizations, and citizens of the State to observe the month with appropriate awareness activities and programs.
AI Summary
This joint resolution designates September of each year as "Duchenne Muscular Dystrophy Awareness Month" in New Jersey, drawing attention to a rare genetic disorder that primarily affects male infants. Duchenne Muscular Dystrophy (DMD) is a serious condition caused by X chromosome mutations, impacting approximately 1 in 3,500 male infants, and characterized by progressive muscle tissue loss and functional decline. The resolution highlights the severe progression of the disease, which typically begins between ages two and three, often leading to wheelchair dependence by age 10-12 and requiring breathing ventilators by age 20, with an average life expectancy of just 25 years. By establishing this awareness month, the resolution aims to promote public understanding, support advocacy efforts, and raise awareness about recent medical advancements in treatment, including genetic testing, stem cell therapies, and gene therapy. The resolution requests that the Governor issue an annual proclamation encouraging state agencies, organizations, and citizens to participate in awareness activities, ultimately hoping to foster empathy, build community support, and potentially improve outcomes for individuals and families affected by this devastating genetic disorder.
Committee Categories
Health and Social Services
Sponsors (2)
Last Action
Introduced, Referred to Assembly Health Committee (on 03/06/2025)
Official Document
bill text
bill summary
Loading...
bill summary
Loading...
bill summary
| Document Type | Source Location |
|---|---|
| State Bill Page | https://www.njleg.state.nj.us/bill-search/2024/AJR219 |
| BillText | https://pub.njleg.gov/Bills/2024/AJR/219_I1.HTM |
Loading...